Increased oxidative stress in children with attention deficit hyperactivity disorder

Redox Report

Volumn 21, Issue 6, 2016, Pages 248-253

  Sezen, Hatice ^a   Kandemir, Hasan ^a   Savik, Emin ^a   Basmacı Kandemir, Sultan ^b   Kilicaslan, Fethiye ^a   Bilinc, Hasan ^a   Aksoy, Nurten ^a  

^a HARRAN UNIVERSITY   (Turkey)

^b Balikligol State Hospital   (Turkey)

Author keywords

Arylesterase; Attention deficit hyperactivity disorder; Oxidative stress; Paraxonase 1

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; ARYLESTERASE; ANTIOXIDANT; ARYLDIALKYLPHOSPHATASE; CARBOXYLESTERASE; PON1 PROTEIN, HUMAN;

ADOLESCENT; AGE; ANTIOXIDANT ACTIVITY; ARTICLE; ATTENTION DEFICIT DISORDER; CHEMICAL PARAMETERS; CHILD; CONTROLLED STUDY; DSM-IV; ENZYME ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; OXIDATIVE STRESS INDEX; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX; TOTAL ANTIOXIDANT STATUS; TOTAL OXIDANT STATUS; METABOLISM; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADOLESCENT; ANTIOXIDANTS; ARYLDIALKYLPHOSPHATASE; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CARBOXYLIC ESTER HYDROLASES; CHILD; FEMALE; HUMANS; MALE; OXIDATION-REDUCTION; OXIDATIVE STRESS;

EID: 84978488626     PISSN: 13510002     EISSN: 17432928     Source Type: Journal    
DOI: 10.1080/13510002.2015.1116729     Document Type: Article

References (44)

1. G.Polanczyk, M.S.de Lima, B.L.Horta, J.Biederman, L.A.Rohde. The worldwide prevalence of ADHD:a systematic review and metaregression analysis. Am J Psychiatry 2007;164(6):942–8. doi:10.1176/ajp.2007.164.6.942
2. E.G.Willcutt. The prevalence of DSM-IV attention-deficit/hyperactivity disorder:a meta-analytic review. Neurotherapeutics 2012;9(3):490–9. doi:10.1007/s13311-012-0135-8
3. K.Cheng, M.K.Myers. Attention deficit hyperactivity disorder. In:E.D.Stubbe, (ed.) Child and adolescent psychiatry. Philadelphia:Lippincott Williams & Wilkins; 2005. p. 53–73.
4. V.A.Harpin. The effect of ADHD on the life of an individual, their family, and community from preschool to adult life. Arch Dis Child 2005;90(Suppl 1):2–7. doi:10.1136/adc.2004.059006
5. A.Durand-Rivera, E.Alatorre-Miguel, E.Zambrano-Sánchez, C.Reyes-Legorreta. Methylphenidate efficacy:immediate versus extended release at short term in Mexican children with ADHD assessed by conners scale and EEG. Neurol Res Int 2015:207801.
6. H.Kandemir, B.G.Kılıç, S.Ekinci, M.Yüce. An evaluation of the quality of life of children with attention-deficit/hyperactivity disorder (ADHD) and their families. Anadolu Psikiyatri Derg 2014;15(3):265–71.
7. J.Kurman, L.Rothschild-Yakar, R.Angel, M.Katz. How good am i? Implicit and explicit self-esteem as a function of perceived parenting styles among children with ADHD. J Atten Disord 2015. doi:10.1177/1087054715569599.
8. I.Takon. Clinical use of a modified release methylphenidate in the treatment of childhood attention deficit hyperactivity disorder. Ann Gen Psychiatry 2011;10:25. doi:10.1186/1744-859X-10-25
9. S.I.Sharp, A.McQuillin, H.M.Gurling. Genetics of attention-deficit hyperactivity disorder (ADHD). Neuropharmacology 2009;57(7–8):590–600. doi:10.1016/j.neuropharm.2009.08.011
10. G.Tripp, J.R.Wickens. Neurobiology of ADHD. Neuropharmacology 2009;57(7–8):579–89. doi:10.1016/j.neuropharm.2009.07.026
11. H.Kandemir, M.E.Erdal, S.Selek, Ö.İ.Ay, I.F.Karababa, S.B.Kandemir, Evaluation of several micro RNA (miRNA) levels in children and adolescents with attention deficit hyperactivity disorder. Neurosci Lett 2014;580:158–62. doi:10.1016/j.neulet.2014.07.060
12. J.Young, S.B.McKinney, B.M.Ross, K.W.Wahle, S.P.Boyle. Biomarkers of oxidative stress in schizophrenic and control subjects. Prostaglandins Leukot Essent Fatty Acids 2007;76(2):73–85. doi:10.1016/j.plefa.2006.11.003
13. S.Selek, H.Herken, M.Bulut, M.F.Ceylan, H.Celik, H.A.Savas, Oxidative imbalance in obsessive compulsive disorder patients:a total evaluation of oxidant-antioxidant status. Prog Neuropsychopharmacol Biol Psychiatry 2008;32(2):487–91. doi:10.1016/j.pnpbp.2007.10.002
14. M.Yumru, H.A.Savas, A.Kalenderoglu, M.Bulut, H.Celik, O.Erel. Oxidative imbalance in bipolar disorder subtypes:a comparative study. Prog Neuropsychopharmacol Biol Psychiatry 2009;33(6):1070–4. doi:10.1016/j.pnpbp.2009.06.005
15. J.Kodydková, L.Vávrová, M.Zeman, R.Jirák, J.Macásek, B.Stanková, Antioxidative enzymes and increased oxidative stress in depressive women. Clin Biochem 2009;42(13–14):1368–74. doi:10.1016/j.clinbiochem.2009.06.006
16. S.Rose, S.Melnyk, O.Pavliv, S.Bai, T.G.Nick, R.E.Frye, Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain. Transl Psychiatry 2012;2:134. doi:10.1038/tp.2012.61
17. H.Kandemir, M.Abuhandan, N.Aksoy, E.Savik, C.Kaya. Oxidative imbalance in child and adolescent patients with obsessive compulsive disorder. J Psychiatr Res 2013;47(11):1831–4. doi:10.1016/j.jpsychires.2013.08.010
18. S.Tsaluchidu, M.Cocchi, L.Tonello, B.K.Puri. Fatty acids and oxidative stress in psychiatric disorders. BMC Psychiatry 2008;8(Suppl 1):5. doi:10.1186/1471-244X-8-S1-S5
19. S.Spahis, M.Vanasse, S.A.Bélanger, P.Ghadirian, E.Grenier, E.Levy. Lipid profile, fatty acid composition and pro- and anti-oxidant status in pediatric patients with attention-deficit/hyperactivity disorder. Prostaglandins Leukot Essent Fatty Acids 2008;79(1–2):47–53. doi:10.1016/j.plefa.2008.07.005
20. D.Oztop, H.Altun, G.Baskol, S.Ozsoy. Oxidative stress in children with attention deficit hyperactivity disorder. Clin Biochem 2012;45(10–11):745–8. doi:10.1016/j.clinbiochem.2012.03.027
21. M.Dvoráková, M.Sivonová, J.Trebatická, I.Skodácek, I.Waczuliková, J.Muchová, The effect of polyphenolic extract from pine bark, Pycnogenol on the level of glutathione in children suffering from attention deficit hyperactivity disorder (ADHD). Redox Rep 2006;11(4):163–72. doi:10.1179/135100006X116664
22. T.F.Varol, T.Guvenir, G.Tas, B.Cakaloz, M.Ormen. Nitric oxide levels in disruptive behavioral disorder. Neuropsychobiology 2006;53(4):176–80. doi:10.1159/000093781
23. M.Bulut, S.Selek, H.S.Gergerlioglu, H.A.Savas, H.R.Yilmaz, M.Yuce, Malondialdehyde levels in adult attention-deficit hyperactivity disorder. J Psychiatry Neurosci 2007;32(6):435–8.
24. S.Selek, H.A.Savas, H.S.Gergerlioglu, M.Bulut, H.R.Yilmaz. Oxidative imbalance in adult attention deficit/hyperactivity disorder. Biol Psychol 2008;79(2):256–9. doi:10.1016/j.biopsycho.2008.06.005
25. M.Harel, A.Aharoni, L.Gaidukov, B.Brumshtein, O.Khersonsky, R.Meged, Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes. Nat Struct Mol Biol 2004;11(5):412–9. Epub 18 April 2004. Erratum in:Nat Struct Mol Biol 2004 Dec;11(12):1253. doi:10.1038/nsmb767
26. M.Gur, M.Aslan, A.Yildiz, R.Demirbag, R.Yilmaz, S.Selek, Paraoxonase and arylesterase activities in coronary artery disease. Eur J Clin Invest 2006;36(11):779–87. doi:10.1111/j.1365-2362.2006.01727.x
27. M.Aslan, M.Kosecik, M.Horoz, S.Selek, H.Celik, O.Erel. Assessment of paraoxonase and arylesterase activities in patients with iron deficiency anemia. Atherosclerosis 2007;191(2):397–402. doi:10.1016/j.atherosclerosis.2006.04.007
28. H.Mabrouk, H.Mechria, A.Mechri, I.Azizi, F.Neffati, W.Douki, Paraoxonase 1 activity and lipid profile in schizophrenic patients. Asian J Psychiatr 2014;9:36–40. doi:10.1016/j.ajp.2013.12.019
29. M.Calik, E.Oguz, S.Sarikaya, O.Kocaturk, B.Koca, H.E.Gungor, An evaluation of serum paraoxonase together with arylesterase activities and oxidative stress in children with intractable epilepsy:a cross-sectional study. Epilepsy Res 2014;108(9):1591–6. doi:10.1016/j.eplepsyres.2014.08.007
30. S.Gunay, C.Savran, U.M.Aksoy, F.Maner, A.Turgay, I.Yargic. The norm study, transliteral equivalence, validity, reliability of adult hyperactivity scale in Turkish adult population. Türkiye'de Psikiyatri 2006;98–107.
31. H.W.Eckerson, M.C.Wyte, B.N.La Du. The human serum paraoxonase/arylesterase polymorphism. Am J Hum Genet 1983;35:1126–38.
32. L.Haagen, A.Brock. A new automated method for phenotyping arylesterase (E.C.3.1.1.2.) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate. Eur J Clin Chem Clim Biochem 1992;30:391–5.
33. O.Erel. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004;37(2):112–9. doi:10.1016/j.clinbiochem.2003.10.014
34. O.Erel. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005;38(12):1103–11. doi:10.1016/j.clinbiochem.2005.08.008
35. M.Kosecik, O.Erel, E.Sevinc, S.Selek. Increased oxidative stress in children exposed to passive smoking. Int J Cardiol 2005;100(1):61–4. doi:10.1016/j.ijcard.2004.05.069
36. E.Archana, P.Pai, B.K.Prabhu, R.P.Shenoy, K.Prabhu, A.Rao. Altered biochemical parameters in saliva of pediatric attention deficit hyperactivity disorder. Neurochem Res 2012;37(2):330–4. doi:10.1007/s11064-011-0616-x
37. C.M.Comim, K.M.Gomes, G.Z.Réus, F.Petronilho, G.K.Ferreira, E.L.Streck, Methylphenidate treatment causes oxidative stress and alters energetic metabolism in an animal model of attention-deficit hyperactivity disorder. Acta Neuropsychiatr 2014;26(2):96–103. doi:10.1017/neu.2013.35
38. M.R.Martins, A.Reinke, F.C.Petronilho, K.M.Gomes, F.Dal-Pizzol, J.Quevedo. Methylphenidate treatment induces oxidative stress in young rat brain. Brain Res 2006;1078(1):189–97. doi:10.1016/j.brainres.2006.01.004
39. M.Kawatani, H.Tsukahara, M.Mayumi. Evaluation of oxidative stress status in children with pervasive developmental disorder and attention deficit hyperactivity disorder using urinary-specific biomarkers. Redox Rep 2011;16(1):45–6. doi:10.1179/174329211X12968219310873
40. M.Ceylan, S.Sener, A.C.Bayraktar, M.Kavutcu. Oxidative imbalance in child and adolescent patients with attention-deficit/hyperactivity disorder. Prog Neuropsychopharmacol Biol Psychiatry 2010;34(8):1491–4. doi:10.1016/j.pnpbp.2010.08.010
41. R.Donev, J.Thome. Inflammation:good or bad for ADHD? Atten Defic Hyperact Disord 2010;2(4):257–66. doi:10.1007/s12402-010-0038-7
42. M.Stoelting, M.Geyer, S.Reuter, R.Reichelt, M.J.Bek, H.Pavenstädt. Alpha/beta hydrolase 1 is upregulated in D5 dopamine receptor knockout mice and reduces O2-production of NADPH oxidase. Biochem Biophys Res Commun 2009;379(1):81–5. doi:10.1016/j.bbrc.2008.12.008
43. J.Wu, H.Xiao, H.Sun, L.Zou, L.Q.Zhu. Role of dopamine receptors in ADHD:a systematic meta-analysis. Mol Neurobiol 2012;45(3):605–20. doi:10.1007/s12035-012-8278-5
44. M.Wiecek, M.Maciejczyk, J.Szymura, Z.Szygula. Changes in oxidative stress and acid–base balance in men and women following maximal-intensity physical exercise. Physiol Res 2015;64(1):93–102.